{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:40:10Z","timestamp":1767825610999,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.vaccine.2013.12.031","type":"journal-article","created":{"date-parts":[[2014,1,13]],"date-time":"2014-01-13T23:17:06Z","timestamp":1389655026000},"page":"2017-2019","source":"Crossref","is-referenced-by-count":19,"title":["Rabies: Underused vaccines, unnecessary deaths"],"prefix":"10.1016","volume":"32","author":[{"given":"Betty","family":"Dodet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N.","family":"Durrheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Rees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.12.031_bib0005","series-title":"Historical Perspective of Rabies in Europe and the Mediterranean Basin. A testament to rabies by Dr Arthur King","article-title":"Rabies in the Ancient World","author":"Neville","year":"2004"},{"key":"10.1016\/j.vaccine.2013.12.031_bib0010","first-page":"309","article-title":"Rabies vaccines: WHO position paper","volume":"32","author":"World Health Organization","year":"2010","journal-title":"WER"},{"key":"10.1016\/j.vaccine.2013.12.031_bib0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1474-4422(13)70038-3","article-title":"Human rabies: neuropathogenesis, diagnosis, and management","volume":"12","author":"Hemachudha","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.vaccine.2013.12.031_bib0020","series-title":"WHO Expert Consultation on Rabies. Second Report. WHO Technical Report Series n\u00b0 982","author":"World Health Organization","year":"2013"},{"issue":"11","key":"10.1016\/j.vaccine.2013.12.031_bib0025","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1586\/erv.11.140","article-title":"From brain passage to cell adaptation: the road of human rabies vaccine development","volume":"10","author":"Wu","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.12.031_bib0030","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2013.12.031_bib0035","series-title":"Human and dog rabies prevention and control. Report of the WHO\/Bill & Melinda Gates Foundation Consultation, Annecy, France, 7\u20139 October 2009","author":"World Health Organization","year":"2010"},{"issue":"7","key":"10.1016\/j.vaccine.2013.12.031_bib0040","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.4161\/hv.24502","article-title":"Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV)","volume":"9","author":"Malerczyk","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2013.12.031_bib0045","article-title":"Preventative childhood vaccination to rabies","author":"Liu","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2013.12.031_bib0050","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(96)10085-4","article-title":"Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants","volume":"349","author":"Lang","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2013.12.031_bib0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.trstmh.2007.11.010","article-title":"Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children","volume":"102","author":"Vien","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2013.12.031_bib0060","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/INF.0b013e3181906351","article-title":"A three-year clinical study on immunogenicnity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children concomitantly with Japanese encephalitis vaccine","volume":"28","author":"Pengsaa","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2013.12.031_bib0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jpeds.2007.02.044","article-title":"Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is imunogenic and safe","volume":"151","author":"Kamoltham","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2013.12.031_bib0070","first-page":"14878","article-title":"Cost comparison of rabies pre-exposure with post-exposure treatment in Thai children","volume":"34","author":"Chulasugandha","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.031_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2013.08.008","article-title":"The role of health economic analyses in vaccine decision making","author":"Black","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.031_bib0080","series-title":"15th Pediatric Infectious Disease Society of the Philippines (PIDSP) Annual Convention","article-title":"Rabies pre-exposure prophylaxis","author":"Quiambao","year":"2008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13017623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13017623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T10:27:12Z","timestamp":1538908032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13017623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":16,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0264410X13017623"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}